Home/Filings/4/0000899243-18-018024
4//SEC Filing

MADDEN DAVID 4

Accession 0000899243-18-018024

CIK 0001399529other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 9:02 PM ET

Size

5.5 KB

Accession

0000899243-18-018024

Insider Transaction Report

Form 4
Period: 2018-06-21
MADDEN DAVID
Director
Transactions
  • Award

    Director Stock Option (right to buy)

    2018-06-21+33,00033,000 total
    Exercise: $13.08Exp: 2028-06-21Common Stock (33,000 underlying)
Footnotes (1)
  • [F1]This option vests monthly over 12 months from June 21, 2018 ("Grant Date") in substantially equal monthly installments, provided that the option will vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each such date or, if earlier, such annual meeting.

Issuer

Dicerna Pharmaceuticals Inc

CIK 0001399529

Entity typeother

Related Parties

1
  • filerCIK 0001230836

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 9:02 PM ET
Size
5.5 KB